Papa, Eleanna
Weller, Michael
Weiss, Tobias
Ventura, Elisa
Burghardt, Isabel
Szabó, Emese
Article History
Received: 19 July 2017
Revised: 30 September 2017
Accepted: 9 October 2017
First Online: 13 December 2017
Competing interest
: M.W. has received research grants from Acceleron, Actelion, Bayer, Isarna, MSD, EMD Pharmaceuticals (Merck, Darmstadt), Novocure, Piqur and Roche and honoraria for lectures or advisory board participation or consulting from BMS, Celldex, Immunocellular Therapeutics, Isarna, Magforce, MSD, EMD Pharmaceuticals (Merck, Darmstadt), Northwest Biotherapeutics, Novocure, Pfizer, Roche, Teva and Tocagen. The remaining authors declare that they have no conflict of interests.